Viewing Study NCT07387861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-06-14 @ 2:39 AM
Study NCT ID: NCT07387861
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-04
First Post: 2026-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic Study
Sponsor: Assiut University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None PI3K/AKT/mTOR pathway View
None Phospho-AKT View
None Phospho-S6 View
None Endocrine therapy View
None Tumor budding View
None TILs View